Sven Lingjaerde - Profile and Investment Details

Investor Profile

Sven Lingjaerde is a Venture Capital based in Switzerland with a diverse investment portfolio that includes companies such as OncoEthix, IntelyCare, Venture Med Group, Amplidata, Endoart, Symetis, Endeavour Vision, Relievant Medsystems, Nfocus Neuromedical, PneumRx, Genevest Consulting Group SA (rebranded Reference Capital in 2019), Reference Capital, Retailo, Flexstone Partners (formerly Euro Private Equity Advisors), SmallRivers, BIND Therapeutics, VertiFlex, Rapid Micro Biosystems, Polares Medical, KobojoCXignited, ReShape Lifesciences, Chrono Therapeutics, CeQur, Gynesonics, Lumeon, Nuvaira, Lumavita, CommProve, SOPHiA GENETICS, V-Wave, Molecular Partners, EndoStim, Spartoo, Tech Tour, Quid, . Over time, Sven Lingjaerde has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sven Lingjaerde is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Genetics, Wellness, Women Founded, Apps, Life Science, Artificial Intelligence (AI), Information Technology (IT), Diabetes, Bioinformatics, Software, Manufacturing, Biotechnology, Genomics, Legal Tech, Employee Benefits, Logistics, Medical, Big Data, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Sven Lingjaerde, as their portfolio suggests a familiarity and interest in this area.

Understanding Sven Lingjaerde’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.